Artigo de peri??dico
Evaluation of biokinetics and dosimetry in [131I]-NaI therapies
Registro en:
2319-0612
1A
8
10.15392/bjrs.v8i1A.1082
0000-0002-4049-6720
Sem Percentil
Autor
LIMA, B.L.
ALMEIDA, J.S.
POTIENS, M.P.A.
PELISSONI, R.A.
SAPIENZA, M.T.
BUCHPIGUEL, C.A.
WILLEGAIGNON, J.
Resumen
This study evaluate the possibility of restricting the current image quantification (ROI) from the whole body to a small area in thigh for therapy planning. Whole body planar images were obtained from 13 patients after the administration of 131I tracer dose, and OLINDA/EXM software was used for internal dose calculation. The average value of half-life time was 16.46 ?? 3.45 h in whole body quantification, compared to 14.07 ?? 2.89 h in thigh. The average absorbed dose in bone marrow from the whole body quantification was 0.0519 ?? 0.0250 mGy/MBq, whilst the absorbed dose provided by the thigh quantification represented 87% of this value, with up to 95% in time reduction for dose calculation. Such doses become similar when a correction factor of 1.13 is applied in thigh dose results (p=0.67), which is within the variation coefficient assumed to internal dosimetry (20%). This study shows the possibility of a significant time reduction in internal dose calculation applied to therapy planning.